Clinical Research Directory
Browse clinical research sites, groups, and studies.
Amplitude Titration to Improve ECT Clinical Outcomes
Sponsor: University of New Mexico
Summary
A randomized controlled trial will compare hippocampal neuroplasticity, antidepressant, and cognitive outcomes between individualized amplitude and fixed 800 mA amplitude ECT in older depressed subjects (n = 25 per group, n = 50 total). Relative to fixed 800 mA ECT: H1: Individualized amplitude arm will have improved RUL antidepressant outcome (IDS-C30 response rates and reduced BT electrode placement switch at V2). H2: Individualized amplitude arm will have improved cognitive outcomes (DKEFS-Verbal Fluency
Official title: Amplitude Titration to Improve ECT Clinical Outcomes Randomized Clinical Trial
Key Details
Gender
All
Age Range
50 Years - Any
Study Type
INTERVENTIONAL
Enrollment
50
Start Date
2023-09-14
Completion Date
2028-01-01
Last Updated
2026-01-26
Healthy Volunteers
No
Conditions
Interventions
Soterix Medical Incorporated 4x1 adapter
Device permits individualized amplitudes
Traditional ECT device
FDA approved ECT device with fixed amplitude.
Locations (1)
University of New Mexico Health Science Center
Albuquerque, New Mexico, United States